Tech Company Financing Transactions
Appello Pharmaceuticals Funding Round
Appello Pharmaceuticals, based in Nashville, raised $10.5 million from Deerfield Capital, Mountain Group Capital and private investors.
Transaction Overview
Company Name
Announced On
6/29/2018
Transaction Type
Venture Equity
Amount
$10,500,000
Round
Series A
Investors
Deerfield Capital (Lead Investor) (William Slattery)
Mountain Group Capital (Lead Investor)
Proceeds Purpose
This initial investment will support the development of novel positive allosteric modulators (PAMs) of the metabotropic glutamate receptor subtype 4 (mGlu4) as an innovative new treatment for Parkinson's disease.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Nashville, TN 37011
USA
Nashville, TN 37011
USA
Phone
Website
Email Address
Overview
Appello Pharmaceuticals is a Nashville, TN based preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson's disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Brian Laden
Browse more venture capital transactions:
Prev: 6/29/2018: BrightFarms venture capital transaction
Next: 6/29/2018: Tastytrade venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs